Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 165

1.

Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q).

Kanagal-Shamanna R, Yin CC, Miranda RN, Bueso-Ramos CE, Wang XI, Muddasani R, Medeiros LJ, Lu G.

Cancer Genet. 2013 Jan-Feb;206(1-2):42-6. doi: 10.1016/j.cancergen.2012.12.005. Epub 2013 Jan 26.

PMID:
23357231
[PubMed - indexed for MEDLINE]
2.

MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).

Nilsson T, Nilsson L, Lenhoff S, Rylander L, Astrand-Grundström I, Strömbeck B, Höglund M, Turesson I, Westin J, Mitelman F, Jacobsen SE, Johansson B.

Genes Chromosomes Cancer. 2004 Nov;41(3):223-31.

PMID:
15334545
[PubMed - indexed for MEDLINE]
3.

Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.

Mauritzson N, Albin M, Rylander L, Billström R, Ahlgren T, Mikoczy Z, Björk J, Strömberg U, Nilsson PG, Mitelman F, Hagmar L, Johansson B.

Leukemia. 2002 Dec;16(12):2366-78.

PMID:
12454741
[PubMed - indexed for MEDLINE]
Free Article
4.

Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 cases.

Merlat A, Lai JL, Sterkers Y, Demory JL, Bauters F, Preudhomme C, Fenaux P.

Leukemia. 1999 Feb;13(2):250-7.

PMID:
10025899
[PubMed - indexed for MEDLINE]
5.

De novo myelodysplastic syndrome (MDS) with deletion of the long arm of chromosome 20: a subtype of MDS with distinct hematological and prognostic features?

Wattel E, Laï JL, Hebbar M, Preudhomme C, Grahek D, Morel P, Bauters F, Fenaux P.

Leuk Res. 1993 Nov;17(11):921-6. Review.

PMID:
8231232
[PubMed - indexed for MEDLINE]
6.

Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms.

Nardi V, Winkfield KM, Ok CY, Niemierko A, Kluk MJ, Attar EC, Garcia-Manero G, Wang SA, Hasserjian RP.

J Clin Oncol. 2012 Jul 1;30(19):2340-7. doi: 10.1200/JCO.2011.38.7340. Epub 2012 May 14.

PMID:
22585703
[PubMed - indexed for MEDLINE]
Free Article
7.

Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: a report on 62 cases.

Braun T, de Botton S, Taksin AL, Park S, Beyne-Rauzy O, Coiteux V, Sapena R, Lazareth A, Leroux G, Guenda K, Cassinat B, Fontenay M, Vey N, Guerci A, Dreyfus F, Bordessoule D, Stamatoullas A, Castaigne S, Terré C, Eclache V, Fenaux P, Adès L.

Leuk Res. 2011 Jul;35(7):863-7. doi: 10.1016/j.leukres.2011.02.008. Epub 2011 Mar 10.

PMID:
21396711
[PubMed - indexed for MEDLINE]
8.

Risk factor analysis in myelodysplastic syndrome patients with del(20q): prognosis revisited.

Liu YC, Ito Y, Hsiao HH, Sashida G, Kodama A, Ohyashiki JH, Ohyashiki K.

Cancer Genet Cytogenet. 2006 Nov;171(1):9-16.

PMID:
17074585
[PubMed - indexed for MEDLINE]
9.

Therapy-related myelodysplastic syndrome/acute myeloid leukemia with del(7)(q22) in a patient with de novo AML.

Kim YG, Cho SY, Park TS, Oh SH, Yoon HJ.

Ann Clin Lab Sci. 2011 Fall;41(1):79-83.

PMID:
21325260
[PubMed - indexed for MEDLINE]
10.

Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.

Morel P, Hebbar M, Lai JL, Duhamel A, Preudhomme C, Wattel E, Bauters F, Fenaux P.

Leukemia. 1993 Sep;7(9):1315-23.

PMID:
8371581
[PubMed - indexed for MEDLINE]
11.

Deletion (20q) as the sole abnormality in Waldenström macroglobulinemia suggests distinct pathogenesis of 20q11 anomaly.

Liu YC, Miyazawa K, Sashida G, Kodama A, Ohyashiki K.

Cancer Genet Cytogenet. 2006 Aug;169(1):69-72.

PMID:
16875940
[PubMed - indexed for MEDLINE]
12.

Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? A clinicopathologic study of 41 cases and correlation of cytogenetic features with treatment regimens.

Reddi DM, Lu CM, Fedoriw G, Liu YC, Wang FF, Ely S, Boswell EL, Louissaint A Jr, Arcasoy MO, Goodman BK, Wang E.

Am J Clin Pathol. 2012 Dec;138(6):855-66. doi: 10.1309/AJCPOP7APGDT9JIU.

PMID:
23161720
[PubMed - indexed for MEDLINE]
Free Article
13.

A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia. The UK Cancer Cytogenetics Group (UKCCG)

Jaju RJ, Haas OA, Neat M, Harbott J, Saha V, Boultwood J, Brown JM, Pirc-Danoewinata H, Krings BW, Müller U, Morris SW, Wainscoat JS, Kearney L.

Blood. 1999 Jul 15;94(2):773-80.

PMID:
10397745
[PubMed - indexed for MEDLINE]
Free Article
14.

Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia.

Pedersen-Bjergaard J, Pedersen M, Roulston D, Philip P.

Blood. 1995 Nov 1;86(9):3542-52.

PMID:
7579462
[PubMed - indexed for MEDLINE]
Free Article
15.

Isolated del(5q) in myeloid malignancies: clinicopathologic and molecular features in 143 consecutive patients.

Patnaik MM, Lasho TL, Finke CM, Knudson RA, Ketterling RP, Chen D, Hoyer JD, Hanson CA, Tefferi A.

Am J Hematol. 2011 May;86(5):393-8. doi: 10.1002/ajh.21984.

PMID:
21523797
[PubMed - indexed for MEDLINE]
16.

[Clinical and cytogenetic features of 29 cases of myelodysplastic syndrome associated with del(20q)].

Qin S, Liu SH, Bo LJ, Liu XP, Li CW, Dai Y, He GS, Shao ZH.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004 Apr;21(2):171-2. Chinese.

PMID:
15079804
[PubMed - indexed for MEDLINE]
17.

Myelodysplastic syndrome with isolated deletion of chromosome 20q: an indolent disease with minimal morphological dysplasia and frequent thrombocytopenic presentation.

Gupta R, Soupir CP, Johari V, Hasserjian RP.

Br J Haematol. 2007 Oct;139(2):265-8. Epub 2007 Aug 30.

PMID:
17764468
[PubMed - indexed for MEDLINE]
18.

Cytogenetically unrelated clones in therapy-related myelodysplasia and acute myeloid leukemia: experience from the Copenhagen series updated to 180 consecutive cases.

Pedersen-Bjergaard J, Timshel S, Andersen MK, Andersen AS, Philip P.

Genes Chromosomes Cancer. 1998 Dec;23(4):337-49.

PMID:
9824207
[PubMed - indexed for MEDLINE]
19.

Therapy-related myeloid neoplasms in 39 Korean patients: a single institution experience.

Huh HJ, Lee SH, Yoo KH, Sung KW, Koo HH, Kim K, Jang JH, Jung C, Kim SH, Kim HJ.

Ann Lab Med. 2013 Mar;33(2):97-104. doi: 10.3343/alm.2013.33.2.97. Epub 2013 Feb 21.

PMID:
23483787
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Hematologic disorders associated with deletions of chromosome 20q: a clinicopathologic study of 107 patients.

Kurtin PJ, Dewald GW, Shields DJ, Hanson CA.

Am J Clin Pathol. 1996 Nov;106(5):680-8.

PMID:
8929482
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk